BioMarin Pharmaceutical
Delaware corporation
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 60 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 64 % · cci-v1
13 active sensors·3 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-13
Compare BioMarin Pharmaceutical with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies